Found: 7
Select item for more details and to access through your institution.
CIGB-258 Exerts Potent Anti-Inflammatory Activity against Carboxymethyllysine-Induced Acute Inflammation in Hyperlipidemic Zebrafish via the Protection of Apolipoprotein A-I.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 8, p. 7044, doi. 10.3390/ijms24087044
- By:
- Publication type:
- Article
CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients.
- Published in:
- Cell Stress & Chaperones, 2021, v. 26, n. 3, p. 515, doi. 10.1007/s12192-021-01197-2
- By:
- Publication type:
- Article
Synergistic Anti-Inflammatory Activity of Lipid-Free Apolipoprotein (apo) A-I and CIGB-258 in Acute-Phase Zebrafish via Stabilization of the apoA-I Structure to Enhance Anti-Glycation and Antioxidant Activities.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 10, p. 5560, doi. 10.3390/ijms25105560
- By:
- Publication type:
- Article
Jusvinza, an anti-inflammatory drug derived from the human heat-shock protein 60, for critically ill COVID-19 patients. An observational study.
- Published in:
- PLoS ONE, 2023, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0281111
- By:
- Publication type:
- Article
A peptide derived from HSP60 reduces proinflammatory cytokines and soluble mediators: a therapeutic approach to inflammation.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1162739
- By:
- Publication type:
- Article
CIGB-814, an altered peptide ligand derived from human heat-shock protein 60, decreases anti-cyclic citrullinated peptides antibodies in patients with rheumatoid arthritis.
- Published in:
- Clinical Rheumatology, 2019, v. 38, n. 3, p. 955, doi. 10.1007/s10067-018-4360-3
- By:
- Publication type:
- Article
Synergistic Anti-Inflammatory Activity of Apolipoprotein A-I and CIGB-258 in Reconstituted High-Density Lipoproteins (rHDL) against Acute Toxicity of Carboxymethyllysine in Zebrafish and Its Embryo.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 2, p. 165, doi. 10.3390/ph17020165
- By:
- Publication type:
- Article